Pyronaridine–Artesunate versus Mefloquine plus Artesunate for Malaria
BACKGROUND: Pyronaridine-artesunate is an artemisinin-based combination therapy under evaluation for the treatment of Plasmodium falciparum and P. vivax malaria. METHODS: We conducted a phase 3, open-label, multicenter, noninferiority trial that included 1271 patients between 3 and 60 years of age f...
Main Authors: | Rueangweerayut, R, Phyo, A, Uthaisin, C, Poravuth, Y, Binh, T, Tinto, H, Pénali, L, Valecha, N, Tien, N, Abdulla, S, Borghini-Fuhrer, I, Duparc, S, Shin, C, Fleckenstein, L |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Massachusetts Medical Society
2012
|
Similar Items
-
Pyronaridine-artesunate versus chloroquine in patients with acute Plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial
by: Poravuth, Y, et al.
Published: (2011) -
Pyronaridine-artesunate for uncomplicated falciparum malaria.
by: Nosten, F
Published: (2010) -
Pharmacokinetic interactions between primaquine and pyronaridine-artesunate in healthy adult Thai subjects.
by: Jittamala, P, et al.
Published: (2015) -
An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia
by: Valecha, N, et al.
Published: (2010) -
An open-label, randomised study of dihydroartemisinin-piperaquine versus artesunate-mefloquine for falciparum malaria in Asia.
by: Valecha, N, et al.
Published: (2010)